Reducing the incidence of gastrointestinal side effects during t

Details Reducing the incidence of gastrointestinal side effects during t Reducing the incidence of gastrointestinal side effects during t

1973-07-10

1976-02-10

Rosen, Sam

Drug, bio-affecting and body treating compositions

Identification or warning feature

Taste or smell or chemical irritation to the eye, nose, or...

424234, 424273, 424274, 424305, 424317, A61K 3119, A61K 3140, A61K 3161

Patent

active

039378012

ABSTRACT:
A method is disclosed for inhibiting and alleviating gastrointestinal side effects often encountered during therapy with antiinflammatory agents such as indomethacin, phenylbutazone, oxyphenylbutazone and the like. The method comprises the administration to a mammal receiving such therapy of a prostaglandin derivative of formula 1, ##SPC1##
In which

REFERENCES:
lippmann - Chem. Abst., Vol. 75, (1971), p. 59247n.

Affiliated with

Also associated with

Rating

Reducing the incidence of gastrointestinal side effects during t does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reducing the incidence of gastrointestinal side effects during t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reducing the incidence of gastrointestinal side effects during t will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-150290